Retrophin takes the ax to its Cam­bridge of­fice as it con­cen­trates on late-stage R&D push

Retrophin is clos­ing up its of­fice in Cam­bridge, MA and con­sol­i­dat­ing op­er­a­tions in its head­quar­ters based in San Diego as it fo­cus­es on push­ing ahead with late-stage R&D.

In a fil­ing with the SEC the biotech said “se­lect” staffers would be re­lo­cat­ed to the West Coast, with re­place­ments be­ing re­cruit­ed for the rest of the po­si­tions af­ter the of­fice is closed by the end of this year.

There was no im­me­di­ate word on how many staffers will be af­fect­ed by the move, but Retrophin es­ti­mat­ed that the re­or­ga­ni­za­tion will cost about $4.5 mil­lion to com­plete. The biotech $RTRX has a mar­ket cap of $740 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER